Wyeth boosts Pfizer's Q4 by $3.3 billion
This article was originally published in Scrip
Executive Summary
Pfizer's acquisition of Wyeth saved it from another period of decline in the fourth quarter as sales from its former competitor helped group revenues grow by 34% to $16.5 billion.